Entrectinib FoundationOne liquid companion diagnostic - Foundation Medicine
Alternative Names: Entrectinib FoundationOne®Liquid CDx - Foundation MedicineLatest Information Update: 20 Jan 2023
At a glance
- Originator Foundation Medicine
- Class Diagnostic agents
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Registered Non-small cell lung cancer; Solid tumours